EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Characterization and Clinical Outcomes of High-Risk Device-Related Thrombus in the Amulet IDE Trial

Jens Erik Nielsen-Kudsk, Boris Schmidt, Stephan Windecker, Neeraj Shah, William Gray, Christopher R Ellis, Konstantinos Koulogiannis, Jordan A Anderson, Ryan Gage, Dhanunjaya Lakkireddy

JACC: Clinical Electrophysiology · 2025-07 · 11 (7) · 1543-1554

DOI: 10.1016/j.jacep.2025.02.016 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JACC: Clinical Electrophysiology, 2025-07. Verfasst von Jens Erik Nielsen-Kudsk und 9 weiteren Autor:innen. Beteiligte Einrichtung: Aarhus University Hospital, Aarhus, Denmark. Electronic address: je.nielsen.kudsk@gmail.com. Hauptthemen laut MEDLINE: Thrombosis, Septal Occluder Device. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Abbott Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Characteristics of device-related thrombus (DRT) may differ between types of left atrial appendage occlusion devices, and the association of different DRT characteristics to clinical outcomes is largely unknown. OBJECTIVES: The incidence, characteristics, and clinical outcomes through 5 years of high- and low-risk DRTs were assessed in the Amulet IDE trial (AMPLATZER Amulet Left Atrial Appendage Occluder [LAAO] Investigational Device Exemption [IDE] Trial). METHODS: An independent core laboratory analyzed all available images at the required 45-day and 12-month visits, and clinical events were reported through 5 years' post-left atrial appendage occlusion. RESULTS: Of the 1,788 patients with a successful device implant, DRT was observed in 3.3% (30 of 903) and 4.5% (40 of 885) of Amulet and Watchman 2.5 device patients throughout 12 months, respectively (P = 0.192). DRTs were successfully classified as high risk if pedunculated, mobile, >3 mm in thickness, or without continuation onto the left atrial wall. A significantly higher incidence of high-risk DRTs was observed on the Watchman 2.5 device (4.0% [35 of 885]) compared with the Amulet occluder (2.2% [20 of 903]) (P = 0.030). Most low-risk DRTs resolved (12 of 15), whereas high-risk DRTs remained mostly unresolved (34 of 55). Through 5 years, all clinical outcome rates were numerically higher in the high-risk DRT group compared with the low-risk DRT or no-DRT group; significance was observed in the composite of stroke, systemic embolism, or cardiovascular death (30.4% vs 19.9%; HR: 1.74; 95% CI: 1.03-2.92; P = 0.037) and cardiovascular death (26.4% vs 14.5%, HR: 2.09; 95% CI: 1.20-3.66; P = 0.009). CONCLUSIONS: High-risk DRTs were observed in a higher number of Watchman 2.5 device patients compared with Amulet occluder patients. The composite of stroke, systemic embolism, or cardiovascular death occurred more often in patients with high-risk DRTs compared with those with low-risk DRTs or no DRTs. (AMPLATZER Amulet Left Atrial Appendage Occluder [LAAO] Investigational Device Exemption [Amulet IDE Trial]; NCT02879448).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombosisSeptal Occluder DeviceHumansFemaleMaleAgedAtrial AppendageMiddle AgedTreatment OutcomeAtrial FibrillationRisk FactorsIncidence

Stichwörter der Autor:innen

AmuletWatchmanatrial fibrillationdevice-related thrombusleft atrial appendage occlusionstroke

Autor:innen und Institutionen

  • Aarhus University Hospital, Aarhus, Denmark. Electronic address: je.nielsen.kudsk@gmail.com.
  • Cardioangiologisches Centrum am Bethanien Krankenhaus, Frankfurt, Germany.
  • Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Independence Health Westmoreland Hospital, Greensburg, Pennsylvania, USA.
  • Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, USA.
  • Vanderbilt Heart Institute, Nashville, Tennessee, USA.

Förderung

  • Abbott Pharmaceuticals

Zitieren

APA

Nielsen-Kudsk, J. E., Schmidt, B., Windecker, S., Shah, N., Gray, W., Ellis, C. R., Koulogiannis, K., Anderson, J. A., Gage, R., & Lakkireddy, D. (2025). Characterization and Clinical Outcomes of High-Risk Device-Related Thrombus in the Amulet IDE Trial. JACC: Clinical Electrophysiology, 11(7), 1543-1554. https://doi.org/10.1016/j.jacep.2025.02.016

Vancouver

Nielsen-Kudsk JE, Schmidt B, Windecker S, Shah N, Gray W, Ellis CR, et al. Characterization and Clinical Outcomes of High-Risk Device-Related Thrombus in the Amulet IDE Trial. JACC: Clinical Electrophysiology. 2025;11(7):1543-1554. doi:10.1016/j.jacep.2025.02.016

BibTeX
@article{NielsenKudsk2025,
  author = {Nielsen-Kudsk, Jens Erik and Schmidt, Boris and Windecker, Stephan and Shah, Neeraj and Gray, William and Ellis, Christopher R and Koulogiannis, Konstantinos and Anderson, Jordan A and Gage, Ryan and Lakkireddy, Dhanunjaya},
  title = {Characterization and Clinical Outcomes of High-Risk Device-Related Thrombus in the Amulet IDE Trial},
  journal = {JACC: Clinical Electrophysiology},
  year = {2025},
  volume = {11},
  number = {7},
  pages = {1543--1554},
  doi = {10.1016/j.jacep.2025.02.016}
}
Kostenlos starten →